Table 1.

Patients’ characteristics.

Patients		44
Age		Median 60	(range 39–73)
Sex
	Male	22	50%
	Female	22	50%
Stage
	I	1	2%
	IIA	6	14%
	IIB	0	0
	IIIA	26	59%
	IIIB	11	25%
ISS
	1	15	34%
	2	8	18%
	3	21	59%
Cytogenetic risk
	High risk	1	5%
	Standard risk	19	95%
Immunoglobulins
	Kappa	2	5%
	Lambda	5	11%
	IgG	33	75%
	IgA	4	9%